Nanosphere Doubles Q2 Revenues, Trims Loss | GenomeWeb

NEW YORK (GenomeWeb News) – Nanosphere reported after the close of the market Tuesday that its second-quarter revenues doubled and it trimmed its net loss on lower R&D spending.

The Northbrook, Ill.-based molecular diagnostics firm generated revenues of $402,237 for the three-month period ended June 30, compared to revenues of $194,715 for the second quarter of 2008. Its product sales increased to $242,740 from $194,715, while it also reported grant and contract revenue of $159,497, compared to no such revenues the year before.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.